2-44942323-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_005413.4(SIX3):c.219C>T(p.Pro73Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00128 in 1,593,348 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00099 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0013 ( 2 hom. )
Consequence
SIX3
NM_005413.4 synonymous
NM_005413.4 synonymous
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 1.13
Publications
0 publications found
Genes affected
SIX3 (HGNC:10889): (SIX homeobox 3) This gene encodes a member of the sine oculis homeobox transcription factor family. The encoded protein plays a role in eye development. Mutations in this gene have been associated with holoprosencephaly type 2. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 2-44942323-C-T is Benign according to our data. Variant chr2-44942323-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 65493.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.13 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000989 (150/151694) while in subpopulation NFE AF = 0.00184 (125/67782). AF 95% confidence interval is 0.00158. There are 0 homozygotes in GnomAd4. There are 71 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SIX3 | NM_005413.4 | c.219C>T | p.Pro73Pro | synonymous_variant | Exon 1 of 2 | ENST00000260653.5 | NP_005404.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SIX3 | ENST00000260653.5 | c.219C>T | p.Pro73Pro | synonymous_variant | Exon 1 of 2 | 1 | NM_005413.4 | ENSP00000260653.3 | ||
| ENSG00000225156 | ENST00000760330.1 | n.135+7947C>T | intron_variant | Intron 1 of 1 | ||||||
| SIX3-AS1 | ENST00000760560.1 | n.389-1490G>A | intron_variant | Intron 1 of 1 | ||||||
| SIX3-AS1 | ENST00000760561.1 | n.366-1490G>A | intron_variant | Intron 1 of 1 |
Frequencies
GnomAD3 genomes AF: 0.000990 AC: 150AN: 151582Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
150
AN:
151582
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000809 AC: 176AN: 217666 AF XY: 0.000919 show subpopulations
GnomAD2 exomes
AF:
AC:
176
AN:
217666
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00131 AC: 1888AN: 1441654Hom.: 2 Cov.: 33 AF XY: 0.00125 AC XY: 898AN XY: 717162 show subpopulations
GnomAD4 exome
AF:
AC:
1888
AN:
1441654
Hom.:
Cov.:
33
AF XY:
AC XY:
898
AN XY:
717162
show subpopulations
African (AFR)
AF:
AC:
9
AN:
33354
American (AMR)
AF:
AC:
14
AN:
44430
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26022
East Asian (EAS)
AF:
AC:
2
AN:
39496
South Asian (SAS)
AF:
AC:
3
AN:
85950
European-Finnish (FIN)
AF:
AC:
0
AN:
37028
Middle Eastern (MID)
AF:
AC:
0
AN:
5688
European-Non Finnish (NFE)
AF:
AC:
1795
AN:
1109740
Other (OTH)
AF:
AC:
65
AN:
59946
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
112
224
336
448
560
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000989 AC: 150AN: 151694Hom.: 0 Cov.: 31 AF XY: 0.000958 AC XY: 71AN XY: 74128 show subpopulations
GnomAD4 genome
AF:
AC:
150
AN:
151694
Hom.:
Cov.:
31
AF XY:
AC XY:
71
AN XY:
74128
show subpopulations
African (AFR)
AF:
AC:
13
AN:
41462
American (AMR)
AF:
AC:
7
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3466
East Asian (EAS)
AF:
AC:
0
AN:
5142
South Asian (SAS)
AF:
AC:
0
AN:
4810
European-Finnish (FIN)
AF:
AC:
0
AN:
10452
Middle Eastern (MID)
AF:
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
AC:
125
AN:
67782
Other (OTH)
AF:
AC:
5
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Holoprosencephaly 2 Benign:2
Aug 29, 2013
GeneReviews
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:curation
- -
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 06, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
Jul 12, 2016
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Uncertain
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.